In summary, presented herein age and SD related modifications in NMDA receptors and NOS activity imply their sensitivity to aging, SD, and general well-being, with potential contribution of described processes to the cognitive decline in the course of normal aging and AD, promoting the neurodegenerative process. The gene discussed is NOS2; the disease is Alzheimer disease.